Industry Briefs: Apr. 23, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
3M Drug Delivery Systems has expanded its pressurized metered dose inhaler fill line at its facility in Northridge, California. Read More
Baxter International will invest $1 billion over the next five years for a new manufacturing facility in Georgia for plasma-derived therapies. Read More
Eisai has amended its license agreement with Teikoku Pharma USA for the Aricept transdermal patch system. Read More
Kemwell Biopharma has expanded its pharmaceutical development laboratories, including a 7500-ft2 cGMP pilot facility, in Bangalore, India, to support pharmaceutical projects from preformulation to finished products.
Merck Millipore, the life-science division of Merck KGaA, has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe during May–June 2012. Click here for the schedule and more details.
Mylan is expanding its operations in Dublin and Galway, Ireland. Read More
Patheon has formed Patheon Certified Consultants, a new consulting services comprised of industry professionals to assist emerging biotechnology and pharmaceutical companies. Read More
West Pharmaceutical Services has dedicated new cleanroom manufacturing capabilities at its Scottsdale, Arizona, pharmaceutical delivery systems engineering center. West will manufacture its Daikyo Crystal Zenith 1-mL long prefillable syringe system at the Scottsdale facility.
People News
AMRI has appointed Christopher Conway and Louis Garguilo as vice-president in its business-development units. Read More
Novasep has appointed Jean-Claude Romain as corporate quality director and Alain Lamproye as director of the company’s bioproduction sites in Belgium. Read More
Quintiles has named Tom Pike as CEO. Read More
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
